COVID-19
“It is health that is the real wealth and not pieces of gold and silver.”
We bring together
Our aim is to reduce the burden of Type-2 Diabetes and Cardiovascular Disease in Sri Lanka.
To achieve this aim, we bring together expertise in the fields of public health, health promotion, health policy, nutrition, community interventions, epigenomics, and genomics and actively engage key stakeholders, decision-makers, and policy makers.
We aim to achieve impact by:
We aim to achieve impact by:
Strengthening disease surveillance mechanisms for T2D and CVD to assess needs, priorities, and performance
Developing frameworks and engaging key stakeholders, decision-makers and policymakers for effective dissemination and implementation of our research
Prioritize interventions for prevention, early detection, and treatment of T2D and CVD, considering efficacy, sustainability, and scalability
Supporting capacity building and investing in high-quality training of both health care workers and translational researchers